Voloridge Investment Management
IONS icon

Voloridge Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Voloridge Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.5M Buy
672,858
+87,888
+15% +$6.94M 0.2% 142
2025
Q4 		$46.3M Sell
584,970
-218,077
-27% -$16.4M 0.16% 159
2025
Q3 		$52.5M Sell
803,047
-51,587
-6% -$2.52M 0.18% 142
2025
Q2 		$33.8M Buy
854,634
+477,430
+127% +$15.6M 0.12% 209
2025
Q1 		$11.4M Buy
377,204
+60,261
+19% +$1.97M 0.04% 527
2024
Q4 		$11.1M Sell
316,943
-63,698
-17% -$2.38M 0.04% 541
2024
Q3 		$15.2M Buy
+380,641
New +$17.7M 0.06% 452
2024
Q2 		– Sell
-191,367
Closed -$8.3M – 1289
2024
Q1 		$8.3M Sell
191,367
-72,754
-28% -$3.47M 0.03% 530
2023
Q4 		$13.4M Buy
+264,121
New +$12.7M 0.05% 407
2023
Q3 		– Sell
-5,348
Closed -$219K – 1494
2023
Q2 		$219K Buy
+5,348
New +$206K ﹤0.01% 1312
2023
Q1 		– Sell
-30,709
Closed -$1.16M – 1472
2022
Q4 		$1.16M Buy
+30,709
New +$1.29M 0.01% 1105
2022
Q2 		– Sell
-189,556
Closed -$7.02M – 1535
2022
Q1 		$7.02M Sell
189,556
-77,289
-29% -$2.53M 0.04% 518
2021
Q4 		$8.12M Buy
+266,845
New +$8.4M 0.04% 530
2020
Q4 		– Sell
-94,905
Closed -$4.5M – 1441
2020
Q3 		$4.5M Buy
+94,905
New +$5.27M 0.04% 471
2019
Q3 		– Sell
-102,063
Closed -$6.56M – 1139
2019
Q2 		$6.56M Buy
102,063
+95,907
+1,558% +$6.78M 0.18% 115
2019
Q1 		$500K Buy
+6,156
New +$397K 0.02% 670
2017
Q1 		– Sell
-83,336
Closed -$3.99M – 580
2016
Q4 		$3.99M Buy
+83,336
New +$3.3M 0.09% 293

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management's IONS Position: Q1 2026 in Review

Voloridge Investment Management increased its Ionis Pharmaceuticals (IONS) stake by 15% in Q1 2026, buying an estimated $6.94M and bringing the position to 672,858 shares worth $50.5M. The position accounts for 0.2% of the portfolio, ranked #142.

Voloridge Investment Management first reported a position in IONS in Q4 2016 and has held it in 17 quarters since. The position peaked at $52.5M in Q3 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Voloridge Investment Management held 672,858 shares of Ionis Pharmaceuticals worth $50.5M as of Q1 2026.
  • Voloridge Investment Management bought 87,888 Ionis Pharmaceuticals shares in Q1 2026, an estimated $6.94M.
  • Ionis Pharmaceuticals made up 0.2% of Voloridge Investment Management's portfolio in Q1 2026, its #142 holding.
  • Voloridge Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2016 and has held it in 17 quarters since.
  • Voloridge Investment Management's Ionis Pharmaceuticals position peaked at $52.5M in Q3 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.